Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neuronetics (STIM) Capital Expenditures (2017 - 2025)

Historic Capital Expenditures for Neuronetics (STIM) over the last 9 years, with Q3 2025 value amounting to $114000.0.

  • Neuronetics' Capital Expenditures fell 7046.63% to $114000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $674000.0, marking a year-over-year decrease of 7012.41%. This contributed to the annual value of $1.5 million for FY2024, which is 3811.73% down from last year.
  • As of Q3 2025, Neuronetics' Capital Expenditures stood at $114000.0, which was down 7046.63% from $252000.0 recorded in Q2 2025.
  • Over the past 5 years, Neuronetics' Capital Expenditures peaked at $1.1 million during Q1 2022, and registered a low of $89000.0 during Q4 2024.
  • In the last 5 years, Neuronetics' Capital Expenditures had a median value of $503000.0 in 2022 and averaged $528526.3.
  • Its Capital Expenditures has fluctuated over the past 5 years, first soared by 59652.17% in 2021, then tumbled by 8987.49% in 2024.
  • Neuronetics' Capital Expenditures (Quarter) stood at $801000.0 in 2021, then crashed by 37.2% to $503000.0 in 2022, then skyrocketed by 74.75% to $879000.0 in 2023, then crashed by 89.87% to $89000.0 in 2024, then increased by 28.09% to $114000.0 in 2025.
  • Its last three reported values are $114000.0 in Q3 2025, $252000.0 for Q2 2025, and $219000.0 during Q1 2025.